Filing Flows › Si-Bone (SIBN) › Recalls, complaints & regulation
Si-Bone (SIBN): recalls and clinical trials
Si-Bone (SIBN) beyond its filings: 1 recall in the last 12 months (1 in five years, 0 Class I); 5 active clinical trials.
Latest recalls
- 2026-10-21 · FDA device · iFuse TORQ Implant System Model/Catalog Number: 10055T(10x55mm), 10060T(10x60mm), 10065T(10x65mm), 10080T(10x55mm), 11580T(11.5x80mm)
Si-Bone's latest quarter
Si-Bone, Q3 2026: revenue $55.7M (+14% year over year), operating margin -7.8%, net loss $3.6M, operating cash flow $5.9M. The chart follows the revenue to costs, profit and cash.
Questions
Has Si-Bone had any recalls?
1 recall on file over five years from the FDA, CPSC and NHTSA; 1 in the last 12 months.
How many clinical trials does Si-Bone have?
5 active studies on ClinicalTrials.gov, 0 in phase 3.
Updated Nov 8, 2026. Read automatically from SEC filings and public data; errors are possible. Not investment advice.